Irritable Bowel Syndrome clinical trials
47 active trials name this condition. Describe your situation to see which ones you may be eligible for.
By location
- Well-being in IBS: Strengths and Happiness (WISH) 2.0
- A Study to Investigate Abdominal Symptoms With Camlipixant Compared With Placebo in Adults With Irritable Bowel Syndrome - Diarrhea (IBS-D) and Irritable Bowel Syndrome - Mixed (IBS-M)
- Low FODMAP Plus PEG 3350 for the Treatment of Patients with Irritable Bowel Syndrome-Constipation
- IBS Skin Patch Test Food Allergy Study
- Home Transcutaneous Electrical Acustimulation (TEA)
- Novel Pilot Study to Treat Symptoms of IBS With Diarrhea Using Combination Therapy of a Low-FODMAP Diet and a Neuromodulator
- Fecal Microbiota Transplantation for IBS
- A Study of Brenipatide (LY3537031) in Participants With Irritable Bowel Syndrome-Diarrhea (IBS-D)
- Home-based Transcutaneous Auricular Vagus Nerve Stimulation (taVNS) for IBS Pain
- A Study of Virtual Reality and Linaclotide for IBS-C
- The Use of Directed Probiotics in ME/CFS: Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
- Mechanisms of Gulf War Illness
- Viome Nutritional Programs to Improve Clinical Outcomes for Gastrointestinal Conditions
- Psyllium in Pediatric IBS
- A Study of Brenipatide (LY3537031) in Participants With Irritable Bowel Syndrome-Constipation (IBS-C)
- A Prospective Trial of a Variable Compression System for Moderate to Severe Irritable Bowel Syndrome
- Visible Abdominal Distension
- Feasibility Study of a Guided Imagery Therapy Mobile Application for Functional Abdominal Pain Disorders in Children
- Online Social Learning Program for Parents With Irritable Bowel Syndrome: Raising Resilient Children
- Objective Integrated Multimodal Electrophysiological Index for the Quantification of Visceral Pain
- Irritable Bowel Syndrome and Control Volunteers: Diet Challenge
- Diet and Motility in IBS
- Prospective Observational Study of Naturopathic Approaches to IBS
- Capsule Microbiota Sampling in IBS/Functional Gastrointestinal Disease
- A Study of Prucalopride in Breastfeeding Women With Constipation
- Mucosal and Microbiota Changes During Acute Campylobacteriosis
- Drug Interaction Potential of Pro-Inflammatory Conditions
- ALPCO Calprotectin CLIA Assay - Measurement of Calprotectin Levels in Human Stool
- Assessing Symptom and Mood Dynamics in Pain Using the Smartphone Application SOMA
- Indiana University Gastrointestinal Motility Diagnosis Registry
- Standardized Yoga & Meditation Program for Stress Reduction for Adolescents With Irritable Bowel Syndrome
- Defining Objective Markers of Compliance for Dietary Therapies in IBS
- Acupuncture Therapy for Pediatric Disorders of Gut-Brain Interaction
- A Study Evaluating the Impact of Regular FODMAP-targeting Digestive Enzyme Blend Use on Gastrointestinal Symptoms in Individuals With Self-Reported Bloating
- Trans Auricular Vagal Nerve Stimulation in Patients With IBS-C
- A Well-Being Intervention for People With IBS
- Psilocybin-Assisted Psychotherapy in Treating Irritable Bowel Syndrome (IBS)
- Use of A Complex Gut Bacterial Consortium (MITI 001) for the Treatment of Irritable Bowel Syndrome With Diarrhea
- A Pilot Study Using Gut-Directed Hypnotherapy for Hospitalized Patients
- Ex-vivo Confocal Imaging and Proteomic Profiling to Determine Treatment Response in Children With IBD
- The Mechanism Underlying the Analgesic Effect of the Music of IBS Pain
- Safety Study of Tenapanor for the Treatment of Pediatric Patients (6 to Less Than 18 Years Old) With IBS-C
- Functional GI Disease Registry
- Enabling Microbiomics- Driven Personalized Nutrition
- Quest to Analyze One Thousand Humans Meditating
- Study to Assess Safety and Efficacy of Tenapanor for Treatment of IBS-C in Pediatric Patients 12 to Less Than 18 Years
- 4-Week, Multi-center Dose-Ranging Study for the IBS-C in Pts. 6 to <12 Yrs
Guides for people searching for a trial
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.
Showing active trials that list “Irritable Bowel Syndrome” as a condition. Eligibility shown on each trial is an estimate — the trial's study team makes the final decision.